Skin Basal Cell Carcinoma: Clinical Trials

8 trials for Skin Basal Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 active not recruiting, 1 withdrawn. 3 Early Phase 1, 3 Phase 2, 2 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 2, Withdrawn 1
Phase 23Completed 2, Active not recruiting 1
Not applicable2Active not recruiting 1, Completed 1
Phase 11Completed 1

Follow Skin Basal Cell Carcinoma: new trials by email Literature Review of Skin Basal Cell Carcinoma trials Research Report on Skin Basal Cell Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
Biopsy Procedure, Natural Killer Cell Therapy, Surgical Procedure - Skin Basal Cell Carcinoma, Skin Nodular Basal Cell Carcinoma
Early Phase 1CompletedOhio State University Comprehensive Cancer Center42025-10-162026-09-28
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
Best Practice, Educational Activity, Patient Observation - Skin Basal Cell Carcinoma
Not applicableActive not recruitingUniversity of Michigan Rogel Cancer Center812024-10-082026-06-23
Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
Arsenic Trioxide, Itraconazole, Laboratory Biomarker Analysis - Skin Basal Cell Carcinoma
Early Phase 1WithdrawnJean Yuh Tang2020-12-012020-10-22
Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer
Remetinostat - Skin Basal Cell Carcinoma
Phase 2CompletedKavita Sarin302018-07-072021-06-08
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive
Phase 2Active not recruitingNational Cancer Institute (NCI)682017-09-272026-11-18
Topical Itraconazole in Treating Patients With Basal Cell Cancer
Itraconazole, Placebo - Skin Basal Cell Carcinoma
Early Phase 1CompletedJean Yuh Tang92016-05-052019-04-11
Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Pembrolizumab, Vismodegib - Skin Basal Cell Carcinoma
Phase 1 / Phase 2CompletedAnne Chang162016-02-012019-03-08
Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery
Therapeutic Conventional Surgery - Skin Basal Cell Carcinoma
Not applicableCompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University1792011-12-072025-04-29

Narrower conditions

Carcinoma, Basal Cell (8)  ·  Adenocarcinoma, Papillary (1)  ·  Carcinoma, Basosquamous (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Signet Ring Cell (1)  ·  Eccrine Porocarcinoma (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Microcystic adnexal carcinoma (1)  ·  Muir-Torre Syndrome (1)  ·  Mycosis Fungoides (1)  ·  Paget Disease, Extramammary (1)  ·  Sezary Syndrome (1)

Broader conditions

Carcinoma (8)  ·  Neoplasms (8)  ·  Neoplasms by Histologic Type (8)  ·  Neoplasms, Basal Cell (8)  ·  Neoplasms, Glandular and Epithelial (8)  ·  Adenocarcinoma (1)  ·  Carcinoma, Neuroendocrine (1)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  DNA Virus Infections (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)

Interventions

Biopsy (2)  ·  Itraconazole (2)  ·  Arsenic Trioxide (1)  ·  HhAntag691 (1)  ·  Nivolumab (1)  ·  Observation (1)  ·  Practice Guidelines as Topic (1)  ·  Specimen Handling (1)  ·  Standard of Care (1)  ·  Surgical Procedures, Operative (1)  ·  Watchful Waiting (1)  ·  arsenous acid (1)  ·  pembrolizumab (1)  ·  remetinostat (1)  ·  talimogene laherparepvec (1)

Sponsors

Jean Yuh Tang (2)  ·  Anne Chang (1)  ·  Kavita Sarin (1)  ·  National Cancer Institute (NCI) (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  University of Michigan Rogel Cancer Center (1)

Countries

United States (7)

Top investigators

Allison Billi (1)  ·  Anne Lynn S Chang, MD (1)  ·  Anthony Oro (1)  ·  Jason Lee, MD (1)  ·  Jean Tang (1)  ·  Kavita Sarin (1)  ·  Kirsten Johnson, MD (1)

Results publications

PMID 38664936

NIH funding

P30CA124435 (2), UM1CA186709 (1), UM1CA186716 (1)